These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 32276105)

  • 21. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key Genes and Immunological Features Associated with Copper Metabolism in Parkinson's Disease by Bioinformatics Analysis.
    Zhang H; Nagai J; Hao L; Jiang X
    Mol Neurobiol; 2024 Feb; 61(2):799-811. PubMed ID: 37659036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    Song J; Li J; Pei X; Chen J; Wang L
    PLoS One; 2024; 19(4):e0299898. PubMed ID: 38626069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of common molecular diagnostic biomarkers between chronic periodontitis and Parkinson's disease via bioinformatics analyses.
    Zehui W; Mengting Z; Pengfei L; Yuanyin W; Jianguang X; Tao W
    J Periodontal Res; 2023 Dec; 58(6):1212-1222. PubMed ID: 37664910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
    Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
    Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Xia MD; Yu RR; Chen DM
    Front Immunol; 2021; 12():809325. PubMed ID: 35069594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of immune signatures in Parkinson's disease based on co-expression networks.
    Dong X; Li Y; Li Q; Li W; Wu G
    Front Genet; 2023; 14():1090382. PubMed ID: 36733342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets.
    Chen M; Zeng J; Yang Y; Wu B
    BMC Oral Health; 2020 Oct; 20(1):279. PubMed ID: 33046027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
    Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis and identification of genes and molecular pathways involved in Parkinson's disease in patients with mutations in the glucocerebrosidase gene.
    Xu DD; Li GQ; Wu ZS; Liu XQ; Yang XX; Wang JH
    Neuroreport; 2021 Aug; 32(11):918-924. PubMed ID: 34132705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia.
    Liu K; Fu Q; Liu Y; Wang C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31416885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis.
    Zhao X; Zhang L; Wang J; Zhang M; Song Z; Ni B; You Y
    J Transl Med; 2021 Jan; 19(1):35. PubMed ID: 33468161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson's Disease in a Mouse Model.
    Jia E; Zhou Y; Liu Z; Wang L; Ouyang T; Pan M; Bai Y; Ge Q
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis.
    Wang K; Zhu R; Li J; Zhang Z; Wen X; Chen H; Sun L
    Clin Rheumatol; 2022 Jun; 41(6):1719-1730. PubMed ID: 35091780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ferroptosis related biomarkers and immune infiltration in Parkinson's disease by integrated bioinformatic analysis.
    Xing N; Dong Z; Wu Q; Zhang Y; Kan P; Han Y; Cheng X; Wang Y; Zhang B
    BMC Med Genomics; 2023 Mar; 16(1):55. PubMed ID: 36918862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HEMGN and SLC2A1 might be potential diagnostic biomarkers of steroid-induced osteonecrosis of femoral head: study based on WGCNA and DEGs screening.
    Wu Z; Wen Y; Fan G; He H; Zhou S; Chen L
    BMC Musculoskelet Disord; 2021 Jan; 22(1):85. PubMed ID: 33451334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.